Stay updated on Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a site build or release change rather than any modification to the clinical trial record.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedPadua, Italy, 35128 was replaced with Padova, Italy, 35128 in the Italy locations list.SummaryDifference0.0%

- Check48 days agoChange DetectedLocation entry updated from Napoli, Italy, 80131 to Naples, Italy, 80131. Revision label updated to v3.5.0, replacing the previous v3.4.3 entry.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check83 days agoChange DetectedThe revision label updated from v3.4.1 to v3.4.2. No study details or results are affected.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.